In order to investigate whether EEBR inhibits NSCLC progression in vivo via the NF‐κB‐NLRP3‐GSDMD pathway by promoting pyroptosis, we evaluated the levels of IL‐1β and IL‐18 in tumour tissues. The gene discussed is GSDMD; the disease is neoplasm.